| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ULTRAGENYX PHARMACEUTICAL INC COM | 110,000 | 12,340,000 | 5.16% | ||
| 2 | AXOGEN INC | 2,120,000 | 10,600,000 | 4.43% | ||
| 3 | FIBROGEN INC COM | 325,000 | 9,903,000 | 4.14% | ||
| 4 | GERON CORP | 1,825,000 | 8,833,000 | 3.69% | ||
| 5 | MEDGENICS INC | 1,390,000 | 8,368,000 | 3.50% | ||
| 6 | IMPRIMIS PHARMACEUTICALS INC | 1,205,000 | 8,351,000 | 3.49% | ||
| 7 | PROTALIX BIOTHERAPEUTICS INC | 8,100,000 | 8,262,000 | 3.45% | ||
| 8 | OPHTHOTECH CORP COM | 105,000 | 8,246,000 | 3.45% | ||
| 9 | ARIAD PHARMACEUTICALS INC | 1,310,000 | 8,188,000 | 3.42% | ||
| 10 | EAGLE PHARMACEUTICALS INC COM | 85,000 | 7,537,000 | 3.15% | ||
| 11 | INOTEK PHARMACEUTICALS CORP | 645,000 | 7,308,000 | 3.06% | ||
| 12 | BLUEPRINT MEDICINES CORP COM | 275,000 | 7,244,000 | 3.03% | ||
| 13 | CARA THERAPEUTICS INC | 427,000 | 7,199,000 | 3.01% | ||
| 14 | CODEXIS INC | 1,600,000 | 6,768,000 | 2.83% | ||
| 15 | RETROPHIN INC COM | 345,000 | 6,655,000 | 2.78% | ||
| 16 | RELYPSA INC | 220,000 | 6,235,000 | 2.61% | ||
| 17 | CEMPRA INC | 200,000 | 6,226,000 | 2.60% | ||
| 18 | SAGE THERAPEUTICS | 100,000 | 5,830,000 | 2.44% | ||
| 19 | SUPERNUS PHARMACEUTICALS INC COM | 420,000 | 5,645,000 | 2.36% | ||
| 20 | DEPOMED INC | 300,000 | 5,439,000 | 2.27% | ||
| 21 | ADAMAS PHARMACEUTICALS INC | 190,000 | 5,380,000 | 2.25% | ||
| 22 | AMAG PHARMACEUTICALS INC COM | 150,000 | 4,529,000 | 1.89% | ||
| 23 | TONIX PHARMACEUTICALS HLD | 565,000 | 4,334,000 | 1.81% | ||
| 24 | AVINGER INC | 190,000 | 4,315,000 | 1.80% | ||
| 25 | AFFIMED N V | 595,000 | 4,236,000 | 1.77% | ||
| 26 | Foamix Pharmaceuticals Ltd. | 500,000 | 4,055,000 | 1.70% | ||
| 27 | EAGLE PHARMACEUTICALS INC | 1,440,000 | 3,816,000 | 1.60% | ||
| 28 | LA JOLLA PHARMACEUTICAL CO | 140,000 | 3,780,000 | 1.58% | ||
| 29 | TG THERAPEUTICS INC COM | 300,000 | 3,579,000 | 1.50% | ||
| 30 | Intec Pharma Ltd | 630,000 | 3,377,000 | 1.41% | ||
| 31 | AMARIN CORP PLC | 1,760,000 | 3,326,000 | 1.39% | ||
| 32 | NEUROCRINE BIOSCIE COM USD0.001 | 55,000 | 3,111,000 | 1.30% | ||
| 33 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 250,000 | 3,053,000 | 1.28% | ||
| 34 | Agile Therapeutics, Inc. | 300,000 | 2,928,000 | 1.22% | ||
| 35 | CORIUM INTERNATIONAL INC | 355,000 | 2,883,000 | 1.21% | ||
| 36 | TRILLIUM THERAPEUTICS INC | 210,000 | 2,648,000 | 1.11% | ||
| 37 | XENON PHARMACEUTICALS INC | 300,000 | 2,412,000 | 1.01% | ||
| 38 | XOMA CORP DEL | 1,700,000 | 2,261,000 | 0.95% | ||
| 39 | ZOGENIX INC | 150,000 | 2,211,000 | 0.92% | ||
| 40 | ALDER BIOPHARMACEUTICALS INC | 65,000 | 2,147,000 | 0.90% | ||
| 41 | Nabriva Therapeutics AG | 220,000 | 2,116,000 | 0.88% | ||
| 42 | AURIS MED HLDG AG | 375,000 | 1,834,000 | 0.77% | ||
| 43 | TENAX THERAPEUTICS INC COM | 540,000 | 1,771,000 | 0.74% | ||
| 44 | CYNAPSUS THERAPEUTICS INC | 110,000 | 1,682,000 | 0.70% | ||
| 45 | ACCELERATE DIAGNOSTICS INC | 75,000 | 1,612,000 | 0.67% | ||
| 46 | CELLECTIS S A | 50,000 | 1,552,000 | 0.65% | ||
| 47 | MACROGENICS INC | 35,000 | 1,084,000 | 0.45% | ||
| 48 | VITAE PHARMACEUTICALS INC | 58,500 | 1,059,000 | 0.44% | ||
| 49 | IMMUNOMEDICS INC | 290,000 | 890,000 | 0.37% | ||
| 50 | ACHAOGEN INC | 125,000 | 718,000 | 0.30% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001546927-16-000408, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
